Date：2021-12-14   Author： View： 30

Ceftriaxone Sodium for Injection(0.25g/1.0g) manufactured by NCPC Hebei Huamin Pharmaceutical Co., Ltd has been approved by National Medical Product Administration Drug Evaluation Center for passing efficacy consistency evaluation of generic drugs. The relevant permit has been issued.  

Ceftriaxone sodium for injection is one of the key anti-infective drugs of NCPC Hebei Huamin. Being included in Chinese National Reimbursement Drug List, Ceftriaxone sodium for injection is mainly used to treat infections caused by sensitive pathogens, such as: sepsis; meningeal disease; disseminated Lyme disease (early and late); abdominal infections (peritoneal disease, biliary tract and gastrointestinal tract infections) ); bone, joint, soft tissue, skin and wound infections; infections in patients with low immunity; kidney and urinary tract infections; respiratory infections, especially lung disease, ENT infections; reproductive system infections; preoperative infection prevention.

Passing efficacy consistency evaluation means ceftriaxone sodium for injection manufactured by NCPC Hebi Huamin is consistent with the originated drug in efficacy, which provides an option to patients with good quality and competitive price. NCPC Hebei Huamin will keep improving competitive power of knock-out products, extend product’s lifecycle and provide more quality medicines and services for patients backed by its powerful R&D innovation capabilities and strong supply chain.

Key words: Chinese medicine international medicine, preparation export business, international pharmaceutical trade

Previous: Piperacilline Sodium and Tazobactam Sodium for injection, Amoxicillin Sodium and Clavulanate Potassium for Injection manufactured by NCPC have passed efficacy consistency evaluation!

Next: NCPC National Party Committee preaches spirit of the Sixth Plenary Session of the Sixteenth Central Committee of the CPC and the Tenth Provincial Party Convention